Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

July 01, 1997; Volume 52,Issue 1

ASPET MEETING REPORT

  • You have access
    Colloquium on Signaling and Molecular Structure in Pharmacology (La Jolla, California, March 11–12, 1997)
    Palmer Taylor, Elliott M. Ross, Paul C. Sternweis, Richard R. Neubig and J. Andrew McCammon
    Molecular Pharmacology July 1997, 52 (1) 1-5; DOI: https://doi.org/10.1124/mol.52.1.1

MINIREVIEW

  • You have access
    High Affinity Glutamate Transporters: Regulation of Expression and Activity
    Georgi Gegelashvili and Arne Schousboe
    Molecular Pharmacology July 1997, 52 (1) 6-15; DOI: https://doi.org/10.1124/mol.52.1.6

Accelerated Communication

  • You have access
    Nonpeptide Mimic of Bradykinin with Long-Acting Properties at the Bradykinin B2 Receptor
    Ichiro Aramori, Junko Zenkoh, Noriyuki Morikawa, Masayuki Asano, Chie Hatori, Hiroe Sawai, Hiroshi Kayakiri, Shigeki Satoh, Takayuki Inoue, Yoshito Abe, Yuki Sawada, Tsuyoshi Mizutani, Noriaki Inamura, Kunio Nakahara, Hitoshi Kojo, Teruo Oku and Yoshitada Notsu
    Molecular Pharmacology July 1997, 52 (1) 16-20; DOI: https://doi.org/10.1124/mol.52.1.16

Articles

  • You have access
    Palmitoylation of the V2 Vasopressin Receptor
    Hamid M. Sadeghi, Giulio Innamorati, Mirabelle Dagarag and Mariel Birnbaumer
    Molecular Pharmacology July 1997, 52 (1) 21-29; DOI: https://doi.org/10.1124/mol.52.1.21
  • You have access
    Cytokine Gene Expression during Ontogeny in Murine Thymus on Activation of the Aryl Hydrocarbon Receptor by 2,3,7,8-Tetrachlorodibenzo-p-dioxin
    Zhi-Wei Lai, Claudia Hundeiker, Ernst Gleichmann and Charlotte Esser
    Molecular Pharmacology July 1997, 52 (1) 30-37; DOI: https://doi.org/10.1124/mol.52.1.30
  • You have access
    Role of Amino- and Carboxyl-Terminal Regions of Gα z in the Recognition of Gi-Coupled Receptors
    Rachel C. Tsu, Maurice K.C. Ho, Lisa Y. Yung, Sushma Joshi and Yung H. Wong
    Molecular Pharmacology July 1997, 52 (1) 38-45; DOI: https://doi.org/10.1124/mol.52.1.38
  • You have access
    Thyroid Regulation of NADPH:Cytochrome P450 Oxidoreductase: Identification of a Thyroid-Responsive Element in the 5′-Flank of the Oxidoreductase Gene
    Kathleen A. O’Leary, Huan-Chen Li, Prabha A. Ram, Patricia McQuiddy, David J. Waxman and Charles B. Kasper
    Molecular Pharmacology July 1997, 52 (1) 46-53; DOI: https://doi.org/10.1124/mol.52.1.46
  • You have access
    Recombinant Advanced Glycation End Product Receptor Pharmacokinetics in Normal and Diabetic Rats
    C. Renard, O. Chappey, M.-P. Wautier, M. Nagashima, E. Lundh, J. Morser, L. Zhao, A.-M. Schmidt, J.-M. Scherrmann and J.-L. Wautier
    Molecular Pharmacology July 1997, 52 (1) 54-62; DOI: https://doi.org/10.1124/mol.52.1.54
  • You have access
    Intracellular Metabolism and Action of Acyclic Nucleoside Phosphonates on DNA Replication
    Vladimir M. Pisarev, Suk-Hee Lee, Michele C. Connelly and Arnold Fridland
    Molecular Pharmacology July 1997, 52 (1) 63-68; DOI: https://doi.org/10.1124/mol.52.1.63
  • You have access
    Structural Basis for Differential Induction of Spermidine/Spermine N 1-Acetyltransferase Activity by Novel Spermine Analogs
    Mirjana Fogel-Petrovic, Debora L. Kramer, Slavoljub Vujcic, John Miller, Jim S. Mcmanis, Raymond J. Bergeron and Carl W. Porter
    Molecular Pharmacology July 1997, 52 (1) 69-74; DOI: https://doi.org/10.1124/mol.52.1.69
  • You have access
    Structure/Activity Relationships in Lysophosphatidic Acid: The 2-Hydroxyl Moiety
    Kevin R. Lynch, Darrin W. Hopper, Steven J. Carlisle, John G. Catalano, Ming Zhang and Timothy L. Macdonald
    Molecular Pharmacology July 1997, 52 (1) 75-81; DOI: https://doi.org/10.1124/mol.52.1.75
  • You have access
    Novel 7-Alkyl Methylenedioxy-Camptothecin Derivatives Exhibit Increased Cytotoxicity and Induce Persistent Cleavable Complexes Both with Purified Mammalian Topoisomerase I and in Human Colon Carcinoma SW620 Cells
    Monica Valenti, Wilberto Nieves-Neira, Glenda Kohlhagen, Kurt W. Kohn, Monroe E. Wall, Mansukh C. Wani and Yves Pommier
    Molecular Pharmacology July 1997, 52 (1) 82-87; DOI: https://doi.org/10.1124/mol.52.1.82
  • You have access
    Stimulation of Protein Kinase C Rapidly Reduces Intracellular Na+ Concentration via Activation of the Na+Pump in OK Cells
    Carlos H. Pedemonte, Thomas A. Pressley, Angel R. Cinelli and Mustafa F. Lokhandwala
    Molecular Pharmacology July 1997, 52 (1) 88-97; DOI: https://doi.org/10.1124/mol.52.1.88
  • You have access
    Development of Resistance of Human Immunodeficiency Virus Type 1 to Dextran Sulfate Associated with the Emergence of Specific Mutations in the Envelope gp120 Glycoprotein
    José A. Esté, Dominique Schols, Karen De Vreese, Kristel Van Laethem, Anne-Mieke Vandamme, Jan Desmyter and Erik De Clercq
    Molecular Pharmacology July 1997, 52 (1) 98-104; DOI: https://doi.org/10.1124/mol.52.1.98
  • You have access
    The μ-Opioid Receptor Down-Regulates Differently from the δ-Opioid Receptor: Requirement of a High Affinity Receptor/G Protein Complex Formation
    Sumita Chakrabarti, Wanling Yang, Ping-Yee Law and Horace H. Loh
    Molecular Pharmacology July 1997, 52 (1) 105-113; DOI: https://doi.org/10.1124/mol.52.1.105
  • You have access
    Lactone Modulation of the γ-Aminobutyric Acid A Receptor: Evidence for a Positive Modulatory Site
    Korwyn L. Williams, Joseph B. Tucker, Geoffrey White, David S. Weiss, James A. Ferrendelli, Douglas F. Covey, James E. Krause and Steven M. Rothman
    Molecular Pharmacology July 1997, 52 (1) 114-119; DOI: https://doi.org/10.1124/mol.52.1.114
  • You have access
    High Affinity Binding of [3H]Propionyl-[Met(O2)11]Substance P(7–11), a Tritiated Septide-Like Peptide, in Chinese Hamster Ovary Cells Expressing Human Neurokinin-1 Receptors and in Rat Submandibular Glands
    Sandrine Sagan, Jean-Claude Beaujouan, Yvette Torrens, Monique Saffroy, Gérard Chassaing, Jacques Glowinski and Solange Lavielle
    Molecular Pharmacology July 1997, 52 (1) 120-127; DOI: https://doi.org/10.1124/mol.52.1.120
  • You have access
    Vasoactive Intestinal Polypeptide and Pituitary Adenylate Cyclase-Activating Polypeptide Receptor Chimeras Reveal Domains That Determine Specificity of Vasoactive Intestinal Polypeptide Binding and Activation
    Hitoshi Hashimoto, Nobuya Ogawa, Nami Hagihara, Kyohei Yamamoto, Kumiko Imanishi, Hiroyuki Nogi, Akiko Nishino, Takashi Fujita, Toshio Matsuda, Shigekazu Nagata and Akemichi Baba
    Molecular Pharmacology July 1997, 52 (1) 128-135; DOI: https://doi.org/10.1124/mol.52.1.128
  • You have access
    Efficacy and Kinetics of Opioid Action on Acutely Dissociated Neurons
    Susan Ingram, Tim J. Wilding, Ed W. McCleskey and John T. Williams
    Molecular Pharmacology July 1997, 52 (1) 136-143; DOI: https://doi.org/10.1124/mol.52.1.136
  • You have access
    The Stability of the Agonist β2-Adrenergic Receptor-Gs Complex: Evidence for Agonist-Specific States
    Andrejs M. Krumins and Roger Barber
    Molecular Pharmacology July 1997, 52 (1) 144-154; DOI: https://doi.org/10.1124/mol.52.1.144
  • You have access
    Differences in Folylpolyglutamate Synthetase and Dihydrofolate Reductase Expression in Human B-Lineage versus T-Lineage Leukemic Lymphoblasts: Mechanisms for Lineage Differences in Methotrexate Polyglutamylation and Cytotoxicity
    Amy J. Galpin, John D. Schuetz, Eric Masson, Yuri Yanishevski, Timothy W. Synold, Julio C. Barredo, Ching-Hon Pui, Mary V. Relling and William E. Evans
    Molecular Pharmacology July 1997, 52 (1) 155-163; DOI: https://doi.org/10.1124/mol.52.1.155
  • You have access
    A Conserved Threonine Residue in the Second Intracellular Loop of the 5-Hydroxytryptamine 1A Receptor Directs Signaling Specificity
    Paola M. C. Lembo, Mohammad H. Ghahremani, Stephen J. Morris and Paul R. Albert
    Molecular Pharmacology July 1997, 52 (1) 164-171; DOI: https://doi.org/10.1124/mol.52.1.164
  • You have access
    Positive Cooperativity of Acetylcholine and Other Agonists with Allosteric Ligands on Muscarinic Acetylcholine Receptors
    Jan Jakubík, Lucie Bačáková, Esam E. El-Fakahany and Stanislav Tuček
    Molecular Pharmacology July 1997, 52 (1) 172-179; DOI: https://doi.org/10.1124/mol.52.1.172

Erratum

  • You have access
    Molecular Pharmacology July 1997, 52 (1) 180; DOI: https://doi.org/10.1124/mol.52.1.180
Back to top
PreviousNext

In this issue

Molecular Pharmacology: 52 (1)
Molecular Pharmacology
Vol. 52, Issue 1
1 Jul 1997
  • Table of Contents
  • About the Cover
  • Index by author
Sign up for alerts

Jump to

  • ASPET MEETING REPORT
  • MINIREVIEW
  • Accelerated Communication
  • Articles
  • Erratum
  • Most Cited
  • Most Read
Loading
  • SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
  • The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints
  • Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases
  • Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
  • The Orphan Human Pregnane X Receptor Mediates the Transcriptional Activation of CYP3A4 by Rifampicin through a Distal Enhancer Module
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics